Fast Five Quiz: Helicobacter pylori

B.S. Anand, MD; Steven F. Moss, MD

Disclosures

January 20, 2022

Molecular testing methods have been developed and validated for fresh, frozen, or paraffin-embedded gastric mucosal biopsies; such testing has also been used effectively with fecal samples, which eliminates the need for endoscopy. Molecular methods such as polymerase chain reaction or fluorescently labeled nucleic acid hybridization can identify many of the mutations known to be responsible for antibiotic resistance.

The presence of resistance to clarithromycin, a macrolide antibiotic, reduces the success of clarithromycin triple therapy by approximately 50%.

Metronidazole resistance lowers eradication rates by approximately 25% in triple therapies; the impact of resistance is less in quadruple therapies and when PPIs are included in the regimen. Increasing the dose and duration of metronidazole improves outcomes in metronidazole-resistant strains, indicating that in vitro metronidazole resistance is not an absolute predictor of eradication failure, unlike clarithromycin and levofloxacin resistance.

Learn more about the treatment of H pylori.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....